Syed Kazmi, M.D. Profile
Syed Kazmi, M.D.

@SyedKazmiMD

Followers
189
Following
58
Statuses
56

Dallas, TX
Joined June 2019
Don't wanna be here? Send us removal request.
@SyedKazmiMD
Syed Kazmi, M.D.
27 days
RT @ASCO: Thrilled to see @ASCO guidelines recommending exercise for patients w/ cancer highlighted in the new @WhiteHouse factsheet. Exerc…
0
13
0
@SyedKazmiMD
Syed Kazmi, M.D.
5 months
RT @CathyEngMD: 👋Join us 10/19-10/20 in #Dallas for @GreatDebatesCME w/my co-Chair @YJanjigianMD and 🤩faculty @mgibson21212 @NataliyaUboha
0
9
0
@SyedKazmiMD
Syed Kazmi, M.D.
7 months
@TimothyJBrownMD better late than never.
0
0
2
@SyedKazmiMD
Syed Kazmi, M.D.
8 months
RT @TimothyJBrownMD: Addition of Nintedenib to gem/abr was safe and well tolerated in a phase 1 trial of mPDAC. Congrats @Salthecancerguy o…
0
1
0
@SyedKazmiMD
Syed Kazmi, M.D.
8 months
RT @LaurenByersMD: As @ASCO winds down, I want to thank the late Dr. Waun Ki Hong for being an unbelievable mentor and supporter for so man…
0
19
0
@SyedKazmiMD
Syed Kazmi, M.D.
9 months
Baqir Jafry did an excellent job presenting real-world data in pancreatic cancer under the guidance of one of our most promising young faculty, Dr. Tim Brown.
Tweet media one
2
6
24
@SyedKazmiMD
Syed Kazmi, M.D.
9 months
In stage 3, adjuvant chemo significantly improved overall survival regardless of MSI-status and risk-stratication
Tweet media one
0
1
2
@SyedKazmiMD
Syed Kazmi, M.D.
1 year
@Dr_R_Kurzrock Thank you Drs. Kurzrock and Hong, for this excellent contribution. It will come in handy soon, when I meet with our leadership to advocate for our phase 1 program
0
0
2
@SyedKazmiMD
Syed Kazmi, M.D.
1 year
RT @JIPOEditors: Learn "How to Build a Successful Phase I Clinical Trials Unit", with customized tips from Drs Razelle Kurzrock and David H…
0
18
0
@SyedKazmiMD
Syed Kazmi, M.D.
1 year
RT @pashtoonkasi: Published today! 📰 @NatureMedicine One of the first #cancer vaccines💉that target #KRAS. Not just G12C. 👇🏾The 2-peptide…
0
420
0
@SyedKazmiMD
Syed Kazmi, M.D.
1 year
RT @neerajaiims: #ESMO23 Presidential session talk by @tompowles1 👉1st time in >30 years, a Rx regimen shows superiority to cisplatin based…
0
77
0
@SyedKazmiMD
Syed Kazmi, M.D.
1 year
RT @pashtoonkasi: 🗞️Just published @JCOPO_ASCO At the intersection of Liquid Biopsies🔄Precision Medicine Pan-cancer assessment of ✅PLASM…
0
22
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
RT @jordanberlin5: @CathyEngMD and I with this great cast of speakers. How do you make GI oncology fun and educational? Join #GDUGI2023 a…
0
3
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
RT @RonaYaeger: Excited to announce that A022004 randomized trial of adjuvant encorafenib + cetuximab vs usual care after standard rx for B…
0
17
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
RT @VanMorrisMD: While adding ipilimumab to nivolumab didn’t move the needle forward like we hoped for our pts w/ met #analcancer , the dri…
0
10
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
RT @NVijayvergiaMD: I am totally using this in clinic for my next patient. What about you @CathyEngMD @KristenCiombor @efratdotan @vwooke @…
0
3
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
RT @littlejonesmd: Representing @utswcancer @UTSWHemeOnc @Parkland at @ASCO sharing how we can improve time toxicity for our underserved ca…
0
9
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
RT @meghar111: So excited to share our paper on MMR-proficient colorectal cancer in #LynchSyndrome, published today in @JCOPO_ASCO! 🔬🧬☺️ #h
0
40
0
@SyedKazmiMD
Syed Kazmi, M.D.
2 years
@TimothyJBrownMD @UTSWNews @UTSWHemeOnc @utswcancer We are looking forward to you joining us.
1
0
1